Tengion's IPO

Tengion raised a round of funding on April 10, 2010. Investors include Public.

Tengion is developing human tissues and organs, derived from a patient's own cells, initially treating spina bifida and spinal cord injury with the neo-bladder…

Articles about Tengion's IPO: